ANEBULO PHARMAC INC vs. NVIDIA Corporation
NVIDIA Corporation (NVDA) comes out ahead, leading on 3 of 3 compared factors.
Size & Scale
| ANEB | NVDA | |
|---|---|---|
| Market Cap | — | $5.20 trillion |
| Revenue (TTM) | — | $253.49 billion |
| Net Income (TTM) | $-7,978,748 | $159.61 billion |
NVDA leads on 2 of 2 size & scale factors.
Valuation
| ANEB | NVDA | |
|---|---|---|
| P/E Ratio | — | 31.93 |
| Price / Book | — | 26.61 |
| Price / Sales | — | 20.52 |
ANEB and NVDA split the valuation factors evenly.
Profitability
| ANEB | NVDA | |
|---|---|---|
| Net Margin | — | 62.97% |
| Return on Equity | -100.53% | 81.65% |
NVDA leads on 1 of 1 profitability factors.
Dividend
| ANEB | NVDA | |
|---|---|---|
| Dividend Yield | — | 0.48% |
| Payout Ratio | — | 15.31 |
ANEB and NVDA split the dividend factors evenly.
Risk & Sentiment
| ANEB | NVDA | |
|---|---|---|
| Short Interest | — | 0.07% |
ANEB and NVDA split the risk & sentiment factors evenly.
Dig deeper: ANEB overview, ANEB financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.